| Peer-Reviewed

Management of Erectile Dysfunction in Chronic Kidney Failure in Congo

Received: 21 December 2021     Accepted: 10 January 2022     Published: 17 January 2022
Views:       Downloads:
Abstract

Objective: To evaluate the management of erectile dysfunction (ED) in chronic kidney failure (CKF) patients in Congo. Patients and method: This was a cross-sectional study with prospective data collection over a period of 9 months, carried out in the nephrology departments of three hospitals in Congo. The IIEF-5 score was used to assess erectile function. We included all CRD patients with ED over 18 years of age. Results: The mean age of the patients was 54.4±(range: 20 years and 81 years). Cardiovascular risk factors were dominated by high blood pressure which accounted for 86 patients (91.5%). BMI was normal in 76 patients (80%). Grade 2 hypertension was noted in 47 patients (49.47%). Two patients (2%) did not have secondary sexual characteristics. The average duration of CKF was 3 years. The onset of ED was preceded by CKF in 92 cases (96.8%). The onset of ED was gradual in 72 cases (78.2%). The circumstance of the occurrence of ED was found in five cases (5.2%). Penile stiffness was low in 86 cases (90.5%). Sixty-four patients (67.4%) did not have a nocturnal erection. Other associated sexual disorders were decreased libido in 46 cases (48.4%), anorgasmia in 53 cases (55.8%) and premature ejaculation in 47 cases (49.47%). The mean IIEF 5 score was 11.38±4.44. Erectile dysfunction was severe in 43 cases (45.2%). Examination of the penis was normal in all cases. Erectile dysfunction was difficult to bear in 51 cases (53.7%). The testosterone level was between 5.5-32 nmol / L in 44 patients (68.8%). FSH and LH levels were increased in 60% of cases. The prolactin level between 1.8 - 29.2 micrograms / l in 14 cases (70%). The medical treatment of erectile dysfunction concerned 36 patients (37.8%). Conclusion: ED has psychological consequences that accentuate the suffering of patients. Modification of these risk factors must be undertaken early. IPDE5 have improved the management of erectile dysfunction

Published in International Journal of Clinical Urology (Volume 6, Issue 1)
DOI 10.11648/j.ijcu.20220601.12
Page(s) 5-9
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2022. Published by Science Publishing Group

Keywords

Chronic Kidney Failure, Erectile Dysfunction, Congo

References
[1] NIH consensus conference: Impotence. NIH Consensus Development Panel Impotence. JAMA, 1993; 270: 83-90.
[2] Kleinclauss F, Kleinclauss C, Bittard H. Dysfonction érectile chez les patients insuffisants rénaux et transplantés rénaux. Prog urol 2005; 15: 447-55.
[3] Droupy S. Épidémiologie et physiopathologie de la dysfonction érectile. annales d'urologie 2005; 39 (2): 71-8.
[4] Diallo Y., Coume M., Ze Ondo C., et al. Dysfonction érectile: profil épidémiologique dans une population de sujets retraités au Sénégal. Andrologie (2012) 22: 241-245.
[5] Amidu N, Owiredu WKBA, Woode E, et al. Prevalence of male sexual dysfunction among Ghanaian populace: myth or reality ? Int J of Impotence Research 2012; 22: 337-42.
[6] Bouya A. P., Odzebe A. W. S., Mayala Maognan R., et al. La dysfonction érectile au Congo: premières données sur la fréquence de ce motif de consultation et profil clinique au centre hospitalier universitaire de Brazzaville. Andrologie 2012; 22: 92-95.
[7] Akbari F., Alavi M., Esteghamati A., et al. Effect of renal transplantation on sperm quality and sex hormone levels. BJU Int., 2003; 92: 281-283.
[8] Ayub W., Fletcher S.: End-stage renal disease and erectile dysfunction. Is there any hope. Nephrol. Dial. Transplant., 2000; 15: 1525-1528.
[9] Oladiji F, Koyode OO, Parakoyi DB. Influence of sociodemographique caracteristic on prevalence of erectile dysfunction in Nigeria. Int J impot Res. 2013 janv; 25 (1): 18-23.
[10] Baka KH, Moudouni SM, Sanda G, Sadiki B, Lakmichi AM. Prévalence de la dysfonction érectile en Urologie. African Journal of Urology (2017) 4: 349-13.
[11] Badri M S. The Declaration of Helsinki on medical research involving human subjects: a review of seventh revision (Medical Education). Journal of Nepal Health Research Council January 2020, 17 (4): 548-552.
[12] Rosen RC, Riley A, Wagner G et al.: The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49 (6): 822-830.
[13] Costa MR, Reis AM, Pereira BP, et al. Associated factors and prevalence of erectile dysfunction in hemodialysis patients. In Braz J Urol 2014; 40 (1): 44-45.
[14] Oueslati I, Ounissi M, Azaiez S, et al. Prévalence et facteurs de risque de la dysfonction érectile chez l’insuffisants rénaux chroniques. African Journal of Urology (2017) 23, 331-337.
[15] Azemar MD, Menard J, Ripert T, et al. Le schéma thérapeutique habituel de la dysfonction érectile est-il adapté après 65 ans ? Prog Urol (2009) 19: 202–8.
[16] Diao B, Ndoye AK, Fall PA, et al. Dysfonction érectile au Sénégal: profil épidémiologique. Androl. 2007; 17 (3): 223-229.
[17] PALMER B. F.: Sexual dysfunction in uremia. J. Am. Soc. Nephrol., 1999; 10: 1381-1388.38.
[18] Peskircioglu L, Tekin MI, Demirag A, et al. Evaluation of erectile function in renal transplant recipients. Transplant Proc. 1998; 30: 747-749.
[19] Phé V, Rouprêt M, Ferhi K, et al. Étiologie et prise en charge de la dysfonction érectile chez le patient diabétique. Progurol 2009; 19: 3-71.
[20] Chen J., Mabjeesh N. J., Greenstein A., et al. Clinical efficacy of sildenafil in patients on chronic dialysis. J. Urol., 2001; 165: 819-821.
[21] Seibel I., Poli De Figueiredo C. E., Teloken C., et al. Efficacy of oral sildenafil in hemodialysis patients with erectile dysfunction. J. Am. Soc. Nephrol., 2002; 13: 2770-2775.
[22] Turk S., Karalezli G., Tonbul H. Z., et al. Erectile dysfunction and the effects of sildenafil treatment in patients on haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol. Dial. Transplant., 2001; 16: 1818-1822.
[23] Ernst E., Pittler M. H. Yohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized clinical trials. J. Urol., 1998; 159: 433-436.
Cite This Article
  • APA Style

    Armel Melvin Ondongo Atipo, Steve Aristide Ondziel-Opara, Daniel Tony Sinomono Eyeni, Gabriel Aime Ossombo, Roland Bertile Banga Mouss, et al. (2022). Management of Erectile Dysfunction in Chronic Kidney Failure in Congo. International Journal of Clinical Urology, 6(1), 5-9. https://doi.org/10.11648/j.ijcu.20220601.12

    Copy | Download

    ACS Style

    Armel Melvin Ondongo Atipo; Steve Aristide Ondziel-Opara; Daniel Tony Sinomono Eyeni; Gabriel Aime Ossombo; Roland Bertile Banga Mouss, et al. Management of Erectile Dysfunction in Chronic Kidney Failure in Congo. Int. J. Clin. Urol. 2022, 6(1), 5-9. doi: 10.11648/j.ijcu.20220601.12

    Copy | Download

    AMA Style

    Armel Melvin Ondongo Atipo, Steve Aristide Ondziel-Opara, Daniel Tony Sinomono Eyeni, Gabriel Aime Ossombo, Roland Bertile Banga Mouss, et al. Management of Erectile Dysfunction in Chronic Kidney Failure in Congo. Int J Clin Urol. 2022;6(1):5-9. doi: 10.11648/j.ijcu.20220601.12

    Copy | Download

  • @article{10.11648/j.ijcu.20220601.12,
      author = {Armel Melvin Ondongo Atipo and Steve Aristide Ondziel-Opara and Daniel Tony Sinomono Eyeni and Gabriel Aime Ossombo and Roland Bertile Banga Mouss and Yannick Dimi Nyanga and Anani Wencesl Severin Odzebe and Prosper Alain Bouya},
      title = {Management of Erectile Dysfunction in Chronic Kidney Failure in Congo},
      journal = {International Journal of Clinical Urology},
      volume = {6},
      number = {1},
      pages = {5-9},
      doi = {10.11648/j.ijcu.20220601.12},
      url = {https://doi.org/10.11648/j.ijcu.20220601.12},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcu.20220601.12},
      abstract = {Objective: To evaluate the management of erectile dysfunction (ED) in chronic kidney failure (CKF) patients in Congo. Patients and method: This was a cross-sectional study with prospective data collection over a period of 9 months, carried out in the nephrology departments of three hospitals in Congo. The IIEF-5 score was used to assess erectile function. We included all CRD patients with ED over 18 years of age. Results: The mean age of the patients was 54.4±(range: 20 years and 81 years). Cardiovascular risk factors were dominated by high blood pressure which accounted for 86 patients (91.5%). BMI was normal in 76 patients (80%). Grade 2 hypertension was noted in 47 patients (49.47%). Two patients (2%) did not have secondary sexual characteristics. The average duration of CKF was 3 years. The onset of ED was preceded by CKF in 92 cases (96.8%). The onset of ED was gradual in 72 cases (78.2%). The circumstance of the occurrence of ED was found in five cases (5.2%). Penile stiffness was low in 86 cases (90.5%). Sixty-four patients (67.4%) did not have a nocturnal erection. Other associated sexual disorders were decreased libido in 46 cases (48.4%), anorgasmia in 53 cases (55.8%) and premature ejaculation in 47 cases (49.47%). The mean IIEF 5 score was 11.38±4.44. Erectile dysfunction was severe in 43 cases (45.2%). Examination of the penis was normal in all cases. Erectile dysfunction was difficult to bear in 51 cases (53.7%). The testosterone level was between 5.5-32 nmol / L in 44 patients (68.8%). FSH and LH levels were increased in 60% of cases. The prolactin level between 1.8 - 29.2 micrograms / l in 14 cases (70%). The medical treatment of erectile dysfunction concerned 36 patients (37.8%). Conclusion: ED has psychological consequences that accentuate the suffering of patients. Modification of these risk factors must be undertaken early. IPDE5 have improved the management of erectile dysfunction},
     year = {2022}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Management of Erectile Dysfunction in Chronic Kidney Failure in Congo
    AU  - Armel Melvin Ondongo Atipo
    AU  - Steve Aristide Ondziel-Opara
    AU  - Daniel Tony Sinomono Eyeni
    AU  - Gabriel Aime Ossombo
    AU  - Roland Bertile Banga Mouss
    AU  - Yannick Dimi Nyanga
    AU  - Anani Wencesl Severin Odzebe
    AU  - Prosper Alain Bouya
    Y1  - 2022/01/17
    PY  - 2022
    N1  - https://doi.org/10.11648/j.ijcu.20220601.12
    DO  - 10.11648/j.ijcu.20220601.12
    T2  - International Journal of Clinical Urology
    JF  - International Journal of Clinical Urology
    JO  - International Journal of Clinical Urology
    SP  - 5
    EP  - 9
    PB  - Science Publishing Group
    SN  - 2640-1355
    UR  - https://doi.org/10.11648/j.ijcu.20220601.12
    AB  - Objective: To evaluate the management of erectile dysfunction (ED) in chronic kidney failure (CKF) patients in Congo. Patients and method: This was a cross-sectional study with prospective data collection over a period of 9 months, carried out in the nephrology departments of three hospitals in Congo. The IIEF-5 score was used to assess erectile function. We included all CRD patients with ED over 18 years of age. Results: The mean age of the patients was 54.4±(range: 20 years and 81 years). Cardiovascular risk factors were dominated by high blood pressure which accounted for 86 patients (91.5%). BMI was normal in 76 patients (80%). Grade 2 hypertension was noted in 47 patients (49.47%). Two patients (2%) did not have secondary sexual characteristics. The average duration of CKF was 3 years. The onset of ED was preceded by CKF in 92 cases (96.8%). The onset of ED was gradual in 72 cases (78.2%). The circumstance of the occurrence of ED was found in five cases (5.2%). Penile stiffness was low in 86 cases (90.5%). Sixty-four patients (67.4%) did not have a nocturnal erection. Other associated sexual disorders were decreased libido in 46 cases (48.4%), anorgasmia in 53 cases (55.8%) and premature ejaculation in 47 cases (49.47%). The mean IIEF 5 score was 11.38±4.44. Erectile dysfunction was severe in 43 cases (45.2%). Examination of the penis was normal in all cases. Erectile dysfunction was difficult to bear in 51 cases (53.7%). The testosterone level was between 5.5-32 nmol / L in 44 patients (68.8%). FSH and LH levels were increased in 60% of cases. The prolactin level between 1.8 - 29.2 micrograms / l in 14 cases (70%). The medical treatment of erectile dysfunction concerned 36 patients (37.8%). Conclusion: ED has psychological consequences that accentuate the suffering of patients. Modification of these risk factors must be undertaken early. IPDE5 have improved the management of erectile dysfunction
    VL  - 6
    IS  - 1
    ER  - 

    Copy | Download

Author Information
  • Urology-Andrology Department, Teaching Hospital of Brazzaville, Brazzaville, Republic of Congo

  • Urology-Andrology Department, Teaching Hospital of Brazzaville, Brazzaville, Republic of Congo

  • Nephrology Department, Teaching Hospital of Brazzaville, Brazzaville, Republic of Congo

  • Urology-Andrology Department, Teaching Hospital of Brazzaville, Brazzaville, Republic of Congo

  • Urology-Andrology Department, Teaching Hospital of Brazzaville, Brazzaville, Republic of Congo

  • Urology-Andrology Department, Teaching Hospital of Brazzaville, Brazzaville, Republic of Congo

  • Urology-Andrology Department, Teaching Hospital of Brazzaville, Brazzaville, Republic of Congo

  • Urology-Andrology Department, Teaching Hospital of Brazzaville, Brazzaville, Republic of Congo

  • Sections